News & Events Upcoming events Oct 21, 2026 - Oct 23, 2026 MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Meeting Toronto, Canada More info and meet us there Nov 16, 2026 - Nov 19, 2026 MEDICA 2026 Düsseldorf, Germany More info and meet us there Nov 16, 2026 - Nov 19, 2026 19th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA, United States of America More info and meet us there See all upcoming events Latest news Jul 24, 2005 Fujirebio Diagnostics, Inc. Names Monte W. Wiltse, Vice President of Sales and Marketing Read more Apr 13, 2005 Fujirebio Diagnostics Expands Commercial Availability of First Blood Test for Mesothelioma Read more Mar 2, 2005 Fujirebio Diagnostics Launches First Blood Test for Mesothelioma Read more Apr 18, 2004 Fujirebio Diagnostics Relocates Key Operations to Expanded, State-of-the-Art Facility Read more Nov 3, 2003 Fujirebio Diagnostics, Inc. Announces New President/COO- World leader in Diagnostic Testing Promotes Paul Touhey Read more Jul 24, 2002 Fujirebio Diagnostics To Develop New Markers For Use With CA 125II For Early Detection Of Ovarian Cancer Read more Load More
Oct 21, 2026 - Oct 23, 2026 MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Meeting Toronto, Canada More info and meet us there
Nov 16, 2026 - Nov 19, 2026 19th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA, United States of America More info and meet us there
Jul 24, 2005 Fujirebio Diagnostics, Inc. Names Monte W. Wiltse, Vice President of Sales and Marketing Read more
Apr 13, 2005 Fujirebio Diagnostics Expands Commercial Availability of First Blood Test for Mesothelioma Read more
Apr 18, 2004 Fujirebio Diagnostics Relocates Key Operations to Expanded, State-of-the-Art Facility Read more
Nov 3, 2003 Fujirebio Diagnostics, Inc. Announces New President/COO- World leader in Diagnostic Testing Promotes Paul Touhey Read more
Jul 24, 2002 Fujirebio Diagnostics To Develop New Markers For Use With CA 125II For Early Detection Of Ovarian Cancer Read more
